Hyderabad-based Bharat Biotech, the manufacturer of COVID-19 Covaxin, said the efficacy of its vaccine would have been 85 per cent against the original strain of the virus.
Pfizer, Moderna vaccines wouldn’t have got nod had they done phase three trials in second wave: Krishna Ella
